All listings for this product
About this product
- DescriptionWith the rapid advancements in medical research, diagstic techlogy and increased public health initiative and awareness, overall cancer death rates in western societies are declining each year with the number of deaths from major cancers such as breast, colorectal and lung following this trend. However, the survival rate for those with pancreatic cancer has been at a standstill for over four decades and there are concerns that pancreatic cancer may become the second deadliest cancer in the US by the year 2030. The diagsis of pancreatic cancer has dire consequences as it presents late in its course and is rapidly progressive. This is clearly one of the most devastating of human cancers, and as there are very few treatment options for those with the disease, new approaches and vel therapeutic strategies are urgently required. For thousands of years, plants have been used as traditional indigeus remedies for a variety of ailments in many parts of the world. It is thought that approximately 80% of the rural population worldwide still relies on plants as medicines. Plants have assumed the greatest prominence as a source of medicinal compounds with thousands of species associated with the treatment of cancers or conditions with cancer-like symptoms. Scientific evaluation of a range of traditional medicines has led to the development of highly effective cancer therapeutic agents, and it is estimated that approximately 50% of all pharmaceuticals currently available for administration are still derived from natural origins. With this in mind, within the plant kingdom there remains great potential for the development of vel therapeutic agents with significant efficacy against pancreatic cancer. With our increasing understanding of the molecular pathology of pancreatic cancer and the rapid advancement of DNA sequencing techlogy to understand the structure of the geme and infer biology, pancreatic cancer is one of the most appropriate diseases to test multiple vel plant derived therapeutics in a molecular phetype driven personalised approach.
- PublisherNova Science Publishers Inc
- Date of Publication01/12/2014
- SubjectClinical Medicine: Professional
- Place of PublicationNew York
- Country of PublicationUnited States
- ImprintNova Science Publishers Inc
- Weight752 g
- Width180 mm
- Height260 mm
- Edited byChristopher J. Scarlett,Quan V. Vuong
Best-selling in Textbooks
Save on Textbooks
- AU $72.90Trending at AU $74.37
- AU $35.06Trending at AU $40.71
- AU $74.90Trending at AU $79.35
- AU $18.96Trending at AU $24.44
- AU $30.00Trending at AU $49.03
- AU $16.98Trending at AU $18.30
- AU $51.96Trending at AU $53.08
This item doesn't belong on this page.
Thanks, we'll look into this.